ArticleEMBO reports2026
Sulf1 regulates inflammation via modulation of TGF-β dependent epicardial activation.
Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Unlike adult humans, zebrafish can regenerate their hearts after injury. After cardiac injury, the epicardium is rapidly activated to contribute both signaling factors and progenitor cells that are essential to establish a pro-regenerative niche. Concurrent with epicardial activation, cardiac injury triggers a robust inflammatory cascade. While the epicardial response is crucial for cardiac regeneration, the mechanisms by which it modulates the immune landscape remain largely unknown. Sulfatases have emerged as important modulators of inflammation through regulating cytokine and growth factor signaling. Here we find that the zebrafish epicardium upregulates the endo-sulfatase Sulf1 after injury. Using newly generated gain- and loss-of-function tools, we show that Sulf1 regulates epicardial activation and regeneration via TGF-β signaling. Abrogation of sulf1 results in cardiomyocyte regeneration defects and increased fibrosis. Moreover, disrupted TGF-β signaling in sulf1 mutants stimulates inflammation and macrophage recruitment. scRNA-seq analyses reveal that epicardial Sulf1 regulates the recruitment of pro-inflammatory macrophage subsets. Epicardial overexpression of sulf1 reverses TGF-β signaling and inflammation phenotypes. These data show that Sulf1 modulates TGF-β-dependent epicardial activation to regulate cardiac inflammation during heart regeneration.
Indexed as
Identifiers
42661063What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.